$EIKN

$5.55 +$0.00 (0.09%) Close

$EIKN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 54.2M shares outstanding

Who owns EIKN?

By type of holder

Institutions 68.0% Insiders 24.8% Everyone else 7.2%

Concentration Top 10 holders own 72.3%

Tim Kutzkey 11.7% · Peter Svennilson 11.7%

Institutional ownership

68.0%

+8.3 pts vs last qtr

Institutional holders

105

+14 vs last qtr

Net shares bought

+4.5M

by institutions in Q2 2026

New / sold out

37 / 23

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +1.3M
FMR LLC +1.2M

Biggest sellers in Q2 2026

Alliancebernstein L.P. −380.3K
Citadel Advisors LLC −332.4K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Eikon Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Eikon Therapeutics, Inc..

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years30% Under 1 year70%

Quarterly turnover

16.2%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting EIKN on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
F FMR LLC	5.0M	9.22%	+1.2M (+30.2%)	Q1 '26	0.0%
Shares held by quarter Peak holding5.0M (Q2'26) Change over 8 quarters+5.0M Share of the company9.220% FMR LLC's full portfolio →
B BlackRock, Inc.	4.7M	8.63%	+1.3M (+39.7%)	2023	0.0%
Shares held by quarter Peak holding4.7M (Q2'26) Change over 8 quarters+4.7M Share of the company8.630% BlackRock, Inc.'s full portfolio →

FMR LLC

5.0M

% of company

9.22%

Change vs last qtr

+1.2M (+30.2%)

Held since

Q1 '26

BlackRock, Inc.

4.7M

% of company

8.63%

Change vs last qtr

+1.3M (+39.7%)

Held since

2023

28 more super investors behind a free account

See every manager holding Eikon Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting EIKN on Form N-PORT; together they hold 21.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FC Fidelity Contrafund Fidelity Contrafund	$16.6M	1.3M	2.36%	0.01%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$15.9M	942.5K	1.74%	0.00%	June 30, 2026

Fidelity Contrafund

Position value

$16.6M

% of company

2.36%

% of the fund

0.01%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$15.9M

% of company

1.74%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Eikon Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
TK Tim Kutzkey 5%+ holder 13D · 11.6%	6.4M	11.73%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company11.730% Disclosed stake13D · 11.6% View the 13D/G filing →
PS Peter Svennilson 5%+ holder 13D · 11.6%	6.4M	11.73%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company11.730% Disclosed stake13D · 11.6% View the 13D/G filing →

Tim Kutzkey

5%+ holder13D · 11.6%

6.4M

% of company

11.73%

Change vs last qtr

—

Held since

—

Peter Svennilson

5%+ holder13D · 11.6%

6.4M

% of company

11.73%

Change vs last qtr

—

Held since

—

10 more holders behind a free account

See every insider and 5%+ holder of Eikon Therapeutics, Inc..

Comments